Navigation Links
WuXi PharmaTech Announces First-Quarter 2011 Results
Date:5/10/2011

U.S. dollar and labor cost inflation, partially offset by a gross margin increase in our manufacturing business
  • GAAP operating margin of 21-22%, non-GAAP operating margin of 24-25%
  • Capital expenditures of $50-60 million
  • GAAP effective tax rate of 17-18% due to an increase in the statutory tax rate of the company's Shanghai and Tianjin legal entities from 11% in 2010 to 15% and 12%, respectively, in 2011

  • The Company provides the following guidance for second-quarter 2011 performance:

  • Total net revenues of $97-99 million
  • Laboratory Services revenues of $79-80 million, Manufacturing Services net revenues of $18-19 million
  • GAAP and non-GAAP operating margins comparable to the first quarter of 2011

  • WUXI PHARMATECH (CAYMAN) INC.UNAUDITED CONSOLIDATED BALANCE SHEETS(in thousands of U.S. dollars, except ordinary share, ADS and par value data)March 31, 2011December 31, 2010Assets:Current assets:Cash and cash equivalents

    147,118

    115,401Restricted cash

    1,699

    1,989Short-term investment

    15,326

    38,084Accounts receivable, net

    68,045

    57,041Inventories

    20,081

    17,277Prepaid expenses and other current assets

    15,029

    15,124   Total current assets267,298

    244,916Non-current assets:Goodwill

    24,845

    23,956Property, plant and equipment, net

    208,550

    205,547Intangible assets, net

    3,807

    4,254Land use rights

    5,376

    5,352Deferred tax assets

    10,082

    10,887Other non-current assets

    2,117

    3,221   Total non-current assets254,777

    253,217   Total assets522,075

    498,133Liabilities and equity:Current liabilities:Short-term and current portion of long-term debt

    4,533

    263Accounts payable

    15,376

    14,800Accrue
    '/>"/>

    SOURCE WuXi PharmaTech (Cayman) Inc
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12

    Related medicine technology :

    1. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
    2. Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials
    3. WuXi PharmaTech Included in the Deloitte Technology Fast 500 Asia Pacific 2009 List for the Sixth Consecutive Year
    4. WuXi PharmaTech Schedules Fourth-Quarter 2009 Earnings Release
    5. WuXi PharmaTech Passes EMEA Inspection of Its GMP Manufacturing and Analytical Testing Facilities in Shanghai
    6. WuXi PharmaTech Enters into Collaboration with J&JPRD, a division of Janssen Pharmaceutica for Preclinical Services and Training
    7. WuXi PharmaTech Schedules First-Quarter 2010 Earnings Release
    8. WuXi PharmaTech Announces First-Quarter 2010 Results
    9. WuXi PharmaTech Appoints Hao Zhou as Chief Financial Officer
    10. WuXi PharmaTech Well Positioned to Continue Growing as Independent Company; Will Receive Breakup Fee of $30 million
    11. WuXi PharmaTech RESCHEDULES Second-Quarter 2010 Earnings Conference Call
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... WASHINGTON , Jan. 23, 2015  A new analysis ... Part D 2015 enrollment data shows that 81 percent ... convenient access and extra discounts at certain pharmacies. The ... "Preferred pharmacy plans are now the foundation of ...
    (Date:1/23/2015)... 2015 /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) is investigating ... Inc. ("Advaxis" or the "Company") (NASDAQ: ADXS ... duties to shareholders. On January 21, 2015, ... that Advaxis had misrepresented the clinical data for its ...
    (Date:1/23/2015)... N.Y. , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. ... its Phase I trial of Lixte,s lead compound, LB‑100, is ... John S. Kovach , M.D., the founder ... planned to be completed at a single site. Accrual of ...
    Breaking Medicine Technology:New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
    ... 2011 Archimedes Pharma Ltd., and its subsidiary, Archimedes ... spray is now available by prescription in U.S. pharmacies. ... in cancer patients 18 years of age and older ... opioid therapy for their underlying persistent cancer pain. The ...
    ... Reportlinker.com announces that a new ... its catalogue: Bare ... Analysis, Competitive Landscape and Market Forecasts ... http://www.reportlinker.com/p0656885/Bare-Metal-Stents-BMS---Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Cardiovascular_Devices Bare Metal ...
    Cached Medicine Technology:Archimedes Pharma Launches Lazanda® - the Only Fentanyl Nasal Spray for the Management of Breakthrough Pain in Cancer in the U.S. 2Archimedes Pharma Launches Lazanda® - the Only Fentanyl Nasal Spray for the Management of Breakthrough Pain in Cancer in the U.S. 3Archimedes Pharma Launches Lazanda® - the Only Fentanyl Nasal Spray for the Management of Breakthrough Pain in Cancer in the U.S. 4Archimedes Pharma Launches Lazanda® - the Only Fentanyl Nasal Spray for the Management of Breakthrough Pain in Cancer in the U.S. 5Archimedes Pharma Launches Lazanda® - the Only Fentanyl Nasal Spray for the Management of Breakthrough Pain in Cancer in the U.S. 6Archimedes Pharma Launches Lazanda® - the Only Fentanyl Nasal Spray for the Management of Breakthrough Pain in Cancer in the U.S. 7Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 2Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 3Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 4Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 5Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 6Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 7Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 8Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 9Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 10Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 11Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 12Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 13
    (Date:1/22/2015)... New York (PRWEB) January 22, 2015 The ... ) in the U.S. District Court, Southern District of West ... Bard, Inc. in that proceeding’s first bellwether trial. In an ... for a new trial after finding that C.R. Bard had ...
    (Date:1/22/2015)... 22, 2015 Thousand of GranuFlo lawsuits ... recalled its GranuFlo and NaturaLyte dialysis concentrates continue to ... U.S. District Court, District of Massachusetts, Bernstein Liebhard LLP ... Court has remanded a case filed by the state ...
    (Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post ... insurance . , Purchasing an accidental death and dismemberment ... This type of rider provides benefits if the insured dies ... a lesser form of life insurance. , AD&D is ...
    (Date:1/22/2015)... 2015 Yesterday, Senator Holly Mitchell ... Kristin Olsen (R-Modesto) were honored by the California ... biotechnology, biomedical science, medical device and pharmaceutical innovation ... the “2014 Life Sciences Champion” award from CHI ...
    (Date:1/22/2015)... Colorado (PRWEB) January 22, 2015 Four years since ... Queen – which coincided with the marriage of Avasa & Matthew ... THE ROAD, which is scheduled for release through White Swan Records ... message that there is a sacred path available to all of ...
    Breaking Medicine News(10 mins):Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4
    ... the October 15 issue of the Journal of Clinical ... (CASQ), a new self-completed instrument to measure excessive daytime ... C. Spilsbury, PhD, of the Division of Clinical Epidemiology ... of 411 adolescents between 11-17 years of age, who ...
    ... Oct. 15 With school schedules now routine and,the ... "not again",sighs. This might be a good time to ... (Photo: http://www.newscom.com/cgi-bin/prnh/20071015/NYFNSL01 ) The following are ... lunch and snacks for greater nutritional impact. Add a,handful ...
    ... Gewurzmuller,s 2006 Sales Totalled US$ 65 M (About Euro 46 M),Frutarom Establishes its ... ... Field Frutarom Continues to Implement ... TASE: FRUT, OTC: FRUTF.PK) ("Frutarom") announced today,that it has signed an agreement to ...
    ... ,Real Women, Real Pain, Campaign Highlights the Suffering Caused ... the World Today, the International Association for the ... Against Pain in Women to draw attention to,the significant ... for more,effective care. Lack of awareness of pain issues ...
    ... Shows Nearly 1 in 3 Believe Nothing Can Be ... Crime as Greatest Risk to Well-Being, CHICAGO, Oct. ... can be done to prevent accidental injuries, posing a ... in the,United States, according to a national survey of ...
    ... study by Rhode Island Hospital and Brown University researchers reported ... not receive the initial psychiatric clearance for the surgery. The ... to clear candidates for surgery, and the largest to determine ... the reasons for exclusion. It was published in the October ...
    Cached Medicine News:Health News:New tool to assess excessive daytime sleepiness in adolescents published in JCSM 2Health News:Fresh, Tasty - Healthy - Lunch and Snack Ideas 2Health News:Frutarom Acquires Gewurzmuller, a Company Specializing in Unique Savory Flavors 2Health News:Frutarom Acquires Gewurzmuller, a Company Specializing in Unique Savory Flavors 3Health News:Frutarom Acquires Gewurzmuller, a Company Specializing in Unique Savory Flavors 4Health News:Frutarom Acquires Gewurzmuller, a Company Specializing in Unique Savory Flavors 5Health News:International Association for the Study of Pain (IASP) Declares the Global Year Against Pain in Women 2Health News:International Association for the Study of Pain (IASP) Declares the Global Year Against Pain in Women 3Health News:Americans' Pessimistic View of Accident Prevention Poses Hurdle to Reducing Injuries, Survey Says 2Health News:Americans' Pessimistic View of Accident Prevention Poses Hurdle to Reducing Injuries, Survey Says 3Health News:1 in 5 bariatric surgery candidates not psychologically cleared for surgery 2
    ... IMMAGE Immunochemistry System gives you ... to perform accurate testing for ... It also delivers a wealth ... your laboratory to streamline its ...
    ... Array systems are fully automated ... fast turnaround of highly accurate ... drug monitoring (TDM) results. Using ... the easy-to-use Array® 360 performs ...
    Inquire...
    ELISA kit for detection of Rheumatoid Factor....
    Medicine Products: